Jubilant Pharmova Ltd — Quarterly Results & Earnings

₹816.45

-1.80%

Profit Growth YoY9.81%Latest quarter

Sales Growth YoY12.22%Latest quarter

Sales CAGR 5Y3.90%5 year compound

Profit CAGR 5Y-9.56%5 year compound

📋

Quarterly Performance

YoY Profit Growth+9.81%

📈 Moderate growth

YoY Sales Growth+12.22%

✅ Strong growth

OPM 5Y Average

Operating profit margin

16.66%

EPS Growth 5Y

-9.56%

Interest Coverage

Higher = safer debt servicing

4.42

ROE

9.55%

ROCE

9.54%

💡

Growth Analysis

Jubilant Pharmova Ltd reported YoY profit growth of 9.81% and revenue growth of 12.22% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 3.90% and profits at -9.56% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Jubilant Pharmova Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.